Insmed (INSM) News Today $72.53 +2.33 (+3.31%) Closing price 03:59 PM EasternExtended Trading$72.66 +0.13 (+0.18%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Insmed’s Chief Commercial Officer Resigns for Personal ReasonsApril 17 at 5:01 PM | tipranks.comInsider Selling: Insmed Incorporated (NASDAQ:INSM) CEO Sells 6,830 Shares of StockApril 17 at 5:19 AM | insidertrades.comEnvestnet Asset Management Inc. Buys 15,227 Shares of Insmed Incorporated (NASDAQ:INSM)Envestnet Asset Management Inc. lifted its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 6.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 256,358 shares of the biopharmaceutical companyApril 17 at 3:25 AM | marketbeat.comWells Fargo & Company MN Buys 33,214 Shares of Insmed Incorporated (NASDAQ:INSM)Wells Fargo & Company MN grew its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 26.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 160,709 shares of the biopharmaceutical company's stock after purchasing an additionApril 17 at 3:24 AM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Bought by Kennedy Capital Management LLCKennedy Capital Management LLC lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 197.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 36,058 shares of the biopharmaceuticalApril 16 at 4:45 AM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by CenterBook Partners LPCenterBook Partners LP cut its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 88.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,391 shares of the biopharmaceutical company's stock afterApril 14 at 5:31 AM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Purchased by Russell Investments Group Ltd.Russell Investments Group Ltd. grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 52.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 132,154 shares of the biopharmaceutical comApril 14 at 4:30 AM | marketbeat.comF M Investments LLC Takes $2.95 Million Position in Insmed Incorporated (NASDAQ:INSM)F M Investments LLC acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 42,793 shares of the biopharmaceutical companApril 13, 2025 | marketbeat.comCommit To Purchase Insmed At $50, Earn 13.9% Annualized Using OptionsApril 13, 2025 | nasdaq.comInsmed Incorporated (NASDAQ:INSM) Shares Purchased by Federated Hermes Inc.Federated Hermes Inc. increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 448.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 235,836 shares of the biopharmaceutical company's stoApril 12, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Acquired by FIL LtdFIL Ltd boosted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 8.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,638,160 shares of the biopharmaceutical company's stock after acquiring an additional 198,412 shares during the quarApril 11, 2025 | marketbeat.comADAR1 Capital Management LLC Has $1.52 Million Holdings in Insmed Incorporated (NASDAQ:INSM)ADAR1 Capital Management LLC boosted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 504.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,974 shares of the biopharmaceutical company'sApril 9, 2025 | marketbeat.comIs Insmed Incorporated (INSM) the Best Long Term Growth Stock to Buy According to Billionaires?April 8, 2025 | msn.comSpringhill Fund Asset Management HK Co Ltd Acquires Shares of 69,500 Insmed Incorporated (NASDAQ:INSM)Springhill Fund Asset Management HK Co Ltd purchased a new stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 69,500 shares of theApril 8, 2025 | marketbeat.comInsmed participates in a conference call with Cantor FitzgeraldApril 8, 2025 | markets.businessinsider.comRhenman & Partners Asset Management AB Has $4.25 Million Stake in Insmed Incorporated (NASDAQ:INSM)Rhenman & Partners Asset Management AB reduced its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 52.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 61,500 shares of the biopharmaceutical company's stock after seApril 7, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC increased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 7.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,087,143April 7, 2025 | marketbeat.comWellington Management Group LLP Trims Holdings in Insmed Incorporated (NASDAQ:INSM)Wellington Management Group LLP lowered its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 21.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 752,226 shares of the biopharmaceutical company's stock after selling 210,233 shares duApril 7, 2025 | marketbeat.comCinctive Capital Management LP Trims Stock Holdings in Insmed Incorporated (NASDAQ:INSM)Cinctive Capital Management LP decreased its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 17.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,252 shares of the biopharmaceutical companyApril 6, 2025 | marketbeat.comRBC Capital Keeps Their Buy Rating on Insmed (INSM)April 5, 2025 | markets.businessinsider.com3,596 Shares in Insmed Incorporated (NASDAQ:INSM) Bought by HighPoint Advisor Group LLCHighPoint Advisor Group LLC acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,596 shares of the bioApril 5, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Schroder Investment Management GroupSchroder Investment Management Group reduced its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 69.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 268,063 sharesApril 4, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Alliancebernstein L.P.Alliancebernstein L.P. lowered its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,363,561 shares of the biopharmaceutical company's stock after selling 86,532 shares durApril 3, 2025 | marketbeat.comInsmed Incorporated (INSM): Insiders Were Dumping in Q1 2025April 2, 2025 | insidermonkey.comNorges Bank Invests $126.61 Million in Insmed Incorporated (NASDAQ:INSM)Norges Bank purchased a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,833,810 shares of the biopharmaceutical company's stock, valued at approximately $126,606,April 2, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Sold by Axiom Investors LLC DEAxiom Investors LLC DE trimmed its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 83,874 shares of the biopharmaceutical company's stock after selling 3,340 shares durApril 1, 2025 | marketbeat.comClearbridge Investments LLC Acquires 69,683 Shares of Insmed Incorporated (NASDAQ:INSM)Clearbridge Investments LLC lifted its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,878,450 shares of thApril 1, 2025 | marketbeat.comNEOS Investment Management LLC Acquires New Shares in Insmed Incorporated (NASDAQ:INSM)NEOS Investment Management LLC bought a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,626 shares of the biopharmaceuticalApril 1, 2025 | marketbeat.comPictet Asset Management Holding SA Grows Position in Insmed Incorporated (NASDAQ:INSM)Pictet Asset Management Holding SA grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 5.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,959,718 shares of the biopharmaceutical company'sMarch 30, 2025 | marketbeat.comPrudential Financial Inc. Grows Position in Insmed Incorporated (NASDAQ:INSM)Prudential Financial Inc. raised its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 146,722 shares of the biopharmaceutMarch 30, 2025 | marketbeat.comVanguard Group Inc. Has $1.26 Billion Stock Position in Insmed Incorporated (NASDAQ:INSM)Vanguard Group Inc. lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 6.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,218,973 shares of the biopharmaMarch 29, 2025 | marketbeat.comKLP Kapitalforvaltning AS Acquires Shares of 33,000 Insmed Incorporated (NASDAQ:INSM)KLP Kapitalforvaltning AS bought a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 33,000 shares of the biopharmaceutical company's stock, valued atMarch 29, 2025 | marketbeat.comLoomis Sayles & Co. L P Has $81.11 Million Stock Position in Insmed Incorporated (NASDAQ:INSM)Loomis Sayles & Co. L P lessened its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 2.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,174,791 shares of the biopharmaceutical company's stock after selling 35,March 28, 2025 | marketbeat.comArtisan Partners Limited Partnership Raises Holdings in Insmed Incorporated (NASDAQ:INSM)Artisan Partners Limited Partnership increased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 8.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,126,339 shares of the biopharmaceMarch 28, 2025 | marketbeat.comBanco BTG Pactual S.A. Buys New Position in Insmed Incorporated (NASDAQ:INSM)Banco BTG Pactual S.A. purchased a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 8,240 shares of the biopharmaceutical company's stock, valued at approximaMarch 27, 2025 | marketbeat.comSei Investments Co. Acquires 29,019 Shares of Insmed Incorporated (NASDAQ:INSM)Sei Investments Co. raised its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 8.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 362,616 shares of the biopharmaceutical company's stock after buying an additional 29,019March 27, 2025 | marketbeat.comAmerican Century Companies Inc. Has $56.11 Million Stake in Insmed Incorporated (NASDAQ:INSM)American Century Companies Inc. grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 812,780 shares of thMarch 27, 2025 | marketbeat.comCorient Private Wealth LLC Has $1.02 Million Position in Insmed Incorporated (NASDAQ:INSM)Corient Private Wealth LLC lifted its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 34.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,730 shares of the biopharmaceutical company's stock after acquiriMarch 27, 2025 | marketbeat.comEFG Asset Management North America Corp. Buys 56,758 Shares of Insmed Incorporated (NASDAQ:INSM)EFG Asset Management North America Corp. raised its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 111.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 107,625 shares of tMarch 26, 2025 | marketbeat.comTeacher Retirement System of Texas Grows Position in Insmed Incorporated (NASDAQ:INSM)Teacher Retirement System of Texas lifted its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 24.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 48,337 shares of the biopharmaceutical company's stock after purchasing an additioMarch 26, 2025 | marketbeat.comIs Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street AnalystsMarch 25, 2025 | msn.comInsmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International ConferenceMarch 25, 2025 | prnewswire.comWells Fargo Sticks to Their Buy Rating for Insmed (INSM)March 24, 2025 | markets.businessinsider.comInsmed Incorporated (NASDAQ:INSM) is Emerald Advisers LLC's 6th Largest PositionEmerald Advisers LLC decreased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 0.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 684,636 shares of the biopharmaceutical company's stock after selling 5,171 sharesMarch 24, 2025 | marketbeat.comSimplify Asset Management Inc. Invests $1.42 Million in Insmed Incorporated (NASDAQ:INSM)Simplify Asset Management Inc. bought a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 20,520 shares of the biopharmaceutical company's stock, valued at apprMarch 24, 2025 | marketbeat.comCibc World Markets Corp Purchases New Stake in Insmed Incorporated (NASDAQ:INSM)Cibc World Markets Corp acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 16,135 shares of the biopharmaceutical company's stock, vaMarch 23, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Given Average Rating of "Buy" by AnalystsShares of Insmed Incorporated (NASDAQ:INSM - Get Free Report) have been given a consensus rating of "Buy" by the sixteen ratings firms that are covering the stock, MarketBeat.com reports. Sixteen research analysts have rated the stock with a buy recommendation. The average 1 year price target amonMarch 23, 2025 | marketbeat.comInsmed price target raised to $96 from $92 at BofAMarch 21, 2025 | markets.businessinsider.comBank of America Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) StockBank of America raised their price target on Insmed from $92.00 to $96.00 and gave the company a "buy" rating in a research note on Thursday.March 21, 2025 | marketbeat.comWilliam Lewis Sells 18,750 Shares of Insmed Incorporated (NASDAQ:INSM) StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 18,750 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $77.03, for a total value of $1,444,312.50. Following the transaction, the chief executive officer now owns 334,186 shares of the company's stock, valued at approximately $25,742,347.58. This represents a 5.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.March 21, 2025 | marketbeat.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼1.380.80▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼1210▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Beigene News Today Summit Therapeutics News Today Royalty Pharma News Today Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today United Therapeutics News Today Genmab A/S News Today BioMarin Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INSM Stock Free INSM Stock Alerts